Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences, and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo utilizes cross-functional teams to develop and deploy products systems and services that meet the ever-changing and rapidly growing needs of health care both today and into the future. Underpinning Enzo’s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies. Enzo has proprietary technologies and expertise in manipulating and modifying genetic material and other biological molecules. Through three wholly-owned subsidiaries (Enzo Therapeutics, Enzo Life Sciences, Enzo Clinical Labs), Enzo targets its technology toward satisfying specific market needs.

Enzo understands and takes extremely seriously its responsibility as a leading and resourceful diagnostic and clinical laboratory in providing COVID-19 testing to the communities we serve in this rapidly evolving pandemic environment. We are doing what we can to alleviate the bottleneck around COVID-19 testing. Read more on how together we are combating a global health pandemic.